JSL
BIIB icon

JT Stratford LLC’s Biogen BIIB Stock Holding History

JT Stratford LLC’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,117
Closed -$387K – 213
2021
Q2 		$387K Buy
1,117
+282
+34% +$85.4K 0.12% 149
2021
Q1 		$234K Buy
+835
New +$225K 0.08% 179
2020
Q1 		– Sell
-744
Closed -$221K – 107
2019
Q4 		$221K Buy
+744
New +$206K 0.1% 131
2019
Q3 		– Sell
-976
Closed -$228K – 162
2019
Q2 		$228K Buy
+976
New +$225K 0.13% 129

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JT Stratford LLC's BIIB Position: Q3 2021 in Review

JT Stratford LLC sold out of Biogen (BIIB) in Q3 2021, closing a stake of 1,117 shares — an estimated $387K sold.

JT Stratford LLC first reported a position in BIIB in Q2 2019 and held it in 4 quarters. The position peaked at $387K in Q2 2021. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • JT Stratford LLC reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • JT Stratford LLC sold 1,117 Biogen shares in Q3 2021, an estimated $387K.
  • JT Stratford LLC first reported a position in Biogen in Q2 2019 and held it in 4 quarters.
  • JT Stratford LLC's Biogen position peaked at $387K in Q2 2021.
  • 1,041 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on JT Stratford LLC's 13F filing for Q3 2021, filed 15 Nov 2021.